Latest papers

FasL gene knock-down therapy enhances the antiglioma immune response.

[The change of CD4+ CD25high CCR6+ regulatory T cells in breast cancer patients].

Regulatory T cell depletion enhances tumor specific CD8 T-cell responses, elicited by tumor antigen NY-ESO-1b in hepatocellular carcinoma patients, in vitro.

[Immunotherapy for melanoma].

Influence of immune privilege on ocular tumor development.

Expression and functional research of TLR4 in human colon carcinoma.

Cancer vaccines: Where are we going?

Altered immune surveillance: a common link between cancer and sepsis?

KIR2DS3 is associated with protection against acute myeloid leukemia.

Crossing the boundaries: stem cells and gene therapy.

Stat3 orchestrates tumor development and progression: the Achilles' heel of head and neck cancers?

Immunomodulatory effects of radiofrequency ablation in a breast cancer model.

Tumor secretion of VEGF induces endothelial cells to suppress T cell functions through the production of PGE2.

Immunological and inflammatory features of Kaposi's sarcoma and other Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8-associated neoplasias.

Mutation or loss of Wilms' tumor gene 1 (WT1) are not major reasons for immune escape in patients with AML receiving WT1 peptide vaccination

Modulation of LMP2A expression by a newly identified Epstein-Barr virus-encoded microRNA miR-BART22.

Depletion of endogenous tumor-associated regulatory T cells improves the efficacy of adoptive cytotoxic T-cell immunotherapy in murine acute myeloid leukemia.

Blockade of B7-H1 or B7-DC induces an anti-tumor effect in a mouse pancreatic cancer model.

PD-1/PD-L1 interactions inhibit antitumor immune responses in a murine acute myeloid leukemia model.

Unwelcome Complement